Aqua Medical Announces First-in-Human Experience of RF Vapor Ablation Therapy for Barrett s Esophagus Published in Endoscopy Entrepreneur and Venture Capitalist William N. (Bill) Starling Joins Board of Directors with Board Advisor Pete Nicholas (Founder of Boston Scientific) and Director Greg Barrett
March 11, 2021 11:00 ET | Source: Aqua Medical Aqua Medical Santa Ana, California, UNITED STATES
Santa Ana, CA, March 11, 2021 (GLOBE NEWSWIRE) Aqua Medical, developer of the FDA 510(k)-cleared vapor-based endoscopic ablation technology for gastrointestinal disease and GI cancer prevention, today announced that clinical results from the first-in-human experience of its RF Vapor Ablation (RFVA) therapy for Barrett s esophagus (BE) were published in Endoscopy.